eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3β and improving autophagy dysfunction.
Guan J, Mo H, Virak V, Guo R, Que D, Yu W, Zhang X, Yan J, Wang Y, Yang Y, Rui B, Huang G, Chen D, Zhong C, Yang P.
Guan J, et al. Among authors: huang g.
Cell Biol Toxicol. 2024 Dec 21;41(1):15. doi: 10.1007/s10565-024-09966-2.
Cell Biol Toxicol. 2024.
PMID: 39708064
Free PMC article.